Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.

The Journal of surgical research - 1 Jan 2010

Chen Jui-yu, Cook Mackenzie R, Pinchot Scott N, Kunnimalaiyaan Muthusamy, Chen Herbert

Abstract excerpt

BACKGROUND: Carcinoid cancers are the most common neuroendocrine (NE) tumors, and limited treatment options exist. The inhibition of glycogen synthase kinase-3beta (GSK-3beta) has been shown to be a potential therapeutic target for the treatment of carcinoid disease. In this study, we investigate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Basic Helix-Loop-Helix Transcription Factors
Share to Carcinoid Tumor
Share to Chromogranin A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cysteine Proteinase Inhibitors

Share to Glycogen Synthase Kinase 3

Share to Glycogen Synthase Kinase 3 beta

Share to Leupeptins

Share to Neurosecretory Systems

Source

Open in PubMed Open full text

Identifiers

PMID: 19765735
DOI: 10.1016/j.jss.2009.05.032
PMCID: PMC2795050

Genes

ASCL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19765735-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.PMID 19765735Read ↗

Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.Semantic proximity Read ↗

Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.Semantic proximity Read ↗

Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.Semantic proximity Read ↗

Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly.Semantic proximity Read ↗

Deregulated GSK3 Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and TelomeraseSemantic proximity Read ↗

Carbonyl cyanide 3-chlorophenylhydrazone promotes of mitophagy in gastric cancer cells MKN1 and MKN45 via PINK1/parkin pathwaySemantic proximity Read ↗

Valproic acid induces Notch1 signaling in small cell lung cancer cells.Semantic proximity Read ↗

Securinine inhibits carcinogenesis in gastric cancer by targeting AURKA-β-catenin/Akt/STAT3 and the cell cycle pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.